Amicus Therapeutics, Inc. (LON:0HF9)
9.18
-0.09 (-0.93%)
At close: Feb 21, 2025
Amicus Therapeutics Employees
Amicus Therapeutics had 517 employees as of December 31, 2023. The number of employees increased by 33 or 6.82% compared to the previous year.
Employees
517
Change (1Y)
33
Growth (1Y)
6.82%
Revenue / Employee
845.66K GBP
Profits / Employee
-89.81K GBP
Market Cap
2.18B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Genus | 3,500 |
Amicus Therapeutics News
- 3 days ago - Amicus Therapeutics files for potential mixed shelf offering - Seeking Alpha
- 3 days ago - SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term Shareholders to Contact the Firm - Business Wire
- 3 days ago - Amicus Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 3 days ago - Amicus Therapeutics, Inc. (FOLD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Amicus Therapeutics Inc (FOLD) Reports Q4 Revenue of $149.7M, Surpassing Estimates of $148.01M - GuruFocus
- 4 days ago - Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates - GlobeNewsWire
- 4 days ago - Amicus Therapeutics FY 2024 Earnings Preview - Seeking Alpha
- 5 days ago - Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm - GlobeNewsWire